Tratamiento farmacológico de la fibromialgia: hacia la neuromodulación química

Price, 2005, Neurobiology of fibromyalgia syndrome, J Rheumatol, 32, 22 Williams, 2006, Biology and therapy of fibromyalgia. Functional magnetic resonance imaging findings in fibromyalgia, Arthritis Res Ther, 8, 224, 10.1186/ar2094 Deus, 2006, Resonancia magnética funcional de la respuesta cerebral al dolor en pacientes con diagnóstico de fibromialgia, Psiq Biol, 13, 39 Yunus, 2005, The concept of central sensitivity syndromes, 29 Russell, 1994, Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome, Arthritis Rheum, 37, 1593, 10.1002/art.1780371106 Vaeroy, 1998, Elevated CSF levels of substance P and high incidence of Raynaud's phenomenon in patients with fibromyalgia: New features for diagnosis, Pain, 32, 21, 10.1016/0304-3959(88)90019-X Giovengo, 1999, Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia, J Rheumatol, 26, 1564 Sarchielli, 2007, Increased levels of neurotrophins are not specific for chronic migraine: Evidence from primary fibromyalgia syndrome, J Pain, 8, 737, 10.1016/j.jpain.2007.05.002 Sarchielli, 2007, Sensitization, glutamate, and the link between migraine and fibromyalgia, Curr Pain Headache Rep, 11, 343, 10.1007/s11916-007-0216-2 Collado, 2009, Incremento de los compuestos de glutamato en el cerebro de los pacientes con fibromialgia: un estudio mediante resonancia espectroscópica, Reumatol Clin, 5, 7 Harris, 2008, Dynamic levels of glutamate within the insula are associated with improvements in multiple pain domains in fibromyalgia, Arthritis and Rheum, 58, 903, 10.1002/art.23223 Desmeules, 2003, Neurophysiologic evidence for a central sensitization in patients with fibromyalgia, Arthritis Rheum, 48, 1420, 10.1002/art.10893 Russell, 1992, Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis, Arthritis Rheum, 35, 550, 10.1002/art.1780350509 Julien, 2005, Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition, Pain, 114, 295, 10.1016/j.pain.2004.12.032 Wood, 2007, Reduced presynaptic dopamine activity in fibromyalgia syndrome demonstrated with positron emission tomography: A pilot study, Pain, 8, 51, 10.1016/j.jpain.2006.05.014 Wood, 2007, Fibromyalgia patients show an abnormal dopamine response to pain, Eur J Neurosci, 25, 3576, 10.1111/j.1460-9568.2007.05623.x Wood, 2008, Role of central dopamine in pain and analgesia, Expert Rev Neurother, 8, 781, 10.1586/14737175.8.5.781 Harris, 2007, Decreased central mu-opioid receptor availability in fibromyalgia, J Neurosci, 27, 10000, 10.1523/JNEUROSCI.2849-07.2007 Collado, 2002, Documento de consenso sobre el diagnóstico y tratamiento de la fibromialgia en Cataluña, Med Clin (Barc), 118, 745, 10.1016/S0025-7753(02)72517-7 Rivera, 2006, Documento de consenso de la Sociedad Española de Reumatología sobre la fibromialgia, Reumatol Clin, 2, S38, 10.1016/S1699-258X(06)73084-4 Carville, 2008, EULAR evidence based recommendations for the management of fibromyalgia syndrome, Ann Rheum Dis, 67, 536, 10.1136/ard.2007.071522 Goldenberg, 2004, Management of fibromyalgia syndrome, JAMA, 292, 2388, 10.1001/jama.292.19.2388 Arnold, 2000, Antidepressant treatment of fibromyalgia: A meta-analysis and review, Psychosomatics, 41, 104, 10.1176/appi.psy.41.2.104 O’Malley, 2000, Treatment of fibromyalgia with antidepressants: A meta-analysis, J Gen Intern Med, 15, 659, 10.1046/j.1525-1497.2000.06279.x Goldenberg, 1996, A randomized double blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia, Arthritis Rheum, 39, 1852, 10.1002/art.1780391111 Tofferi, 2004, Treatment of fibromyalgia with cyclobenzaprine: A meta-analysis, Arthritis Rheum, 51, 9, 10.1002/art.20076 Arnold, 2004, A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder, Arthritis Rheum, 50, 2974, 10.1002/art.20485 Arnold, 2005, A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder, Pain, 119, 5, 10.1016/j.pain.2005.06.031 Russell, 2008, Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial, Pain, 136, 432, 10.1016/j.pain.2008.02.024 Vitton, 2004, A double blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia, Hum Psychopharmacol, 19, 27, 10.1002/hup.622 Gendreau, 2005, Efficacy of milnacipran in patients with fibromyalgia, J Rheumatol, 32, 1975 Clauw, 2008, Milnacipran for the treatment of fibromyalgia in adults: A 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial, Clin Ther, 30, 1988, 10.1016/j.clinthera.2008.11.009 Mease, 2009, The efficacy and safety of milnacipran for treatment of fibromyalgia. A randomized, double-blind, placebo-controlled trial, J Rheumatol, 36, 398, 10.3899/jrheum.080734 Biasi, 1998, Tramadol in the fibromyalgia syndrome: A controlled clinical trial versus placebo, Int J Clin Pharmacol Res, 18, 13 Bennett, 2003, Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain, Am J Med, 114, 537, 10.1016/S0002-9343(03)00116-5 Bennett, 2005, Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen, Arthritis Rheum, 53, 519, 10.1002/art.21319 Holman, 2005, A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications, Arthritis Rheum, 52, 2495, 10.1002/art.21191 Scharf, 2003, The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia, J Rheumatol, 30, 1070 Russell, 2009, Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: A randomized, double-blind, placebo-controlled, multicenter clinical trial, Arthritis Rheum, 60, 299, 10.1002/art.24142 Dooley, 2007, Ca2+ channel α2δligands: Novel modulators of neurotransmission, Trends Pharmacol Sci, 28, 75, 10.1016/j.tips.2006.12.006 Arnold, 2007, Gabapentin in the treatment of fibromyalgia: A randomized, double-blind, placebo controlled, multicenter trial, Arthritis Rheum, 56, 1336, 10.1002/art.22457 Crofford, 2005, Pregabalin for the treatment of fibromyalgia syndrome: Results of a randomized, double-blind, placebo-controlled trial, Arthritis Rheum, 52, 1264, 10.1002/art.20983 Arnold, 2008, A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia, J Pain, 9, 792, 10.1016/j.jpain.2008.03.013 Mease, 2008, A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia, J Rheumatol, 35, 502 Crofford, 2008, Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): A 6-month, double-blind, placebo-controlled trial with pregabalin, Pain, 136, 419, 10.1016/j.pain.2008.02.027 Sörenson, 1997, Fibromyalgia: Are there different mechanisms in the processing of pain? A double blind crossover comparison of analgesic drugs, J Rheumatol, 24, 1615 Graven-Nielsen, 2000, Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients, Pain, 85, 483, 10.1016/S0304-3959(99)00308-5 Cohen, 2006, The intravenous ketamine test predicts subsequent response to an oral dextromethorphan treatment regimen in fibromyalgia patients, J Pain, 7, 391, 10.1016/j.jpain.2005.12.010 Bennett, 2007, An internet survey of 2,596 people with fibromyalgia, BMC Musculoskelet Disord, 9, 8